Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: the special case of molnupiravir
et al., Environmental and Molecular Mutagenesis,
Review of antiviral nucleoside analog drugs that induce lethal mutagenesis, including molnupiravir and favipiravir, and the potential mutagenic risks to human DNA and human mitochondrial DNA. Author recommends monitoring for mutagenicity, carcinogenicity, teratogenicity, and embryotoxicity.
Waters et al., 28 Jan 2022, USA, peer-reviewed, 5 authors.